Drug Utilization Evaluation of Vancomycin in Pediatric Department

Farzaneh Dehghan, Narges Khorami, Naeeme Taslimi Taleghani, Azita Bassiri, Parivash Davoodian, Fariba Shirvani, Nader Zolghadri, Simin Dokht Shoaei



Background: Increasing reports of Vancomycin resistance have raised concerns about effectiveness of this drug. One of the most important factors of resistance emergence is no adherence of physician to principles of antibiotic therapy. This study is a drug utilization evaluation (DUE) of Vancomycin in pediatric ward to assess appropriateness of drug regimens and to find possible problems in clinical practices that may necessitate reconciliation to improve Vancomycin use.

Materials and Methods: This prospective study was done for 1year from October 2014 to September 2015 at Khalij Fars General Hospital in Bandar Abbas. Data including patients’ demographics, paraclinic, diagnosis, vancomycin dose, and treatment duration were collected. The concordance of practice with standard guidelines (CDC, ASHP, and IDSA) and principles of antibiotic therapy was assessed. Results were analyzed by SPSS 20.

Results: 102 medical records were reviewed in this study. Pneumonia (60=59%) and sepsis (22=21.5%) were the most common diagnosis. Sampling was done in 6% of patients with 2% antibiogram. Vancomycin was administered appropriately in 56.9% percent of patients with no sex difference (PV= 0.55) but age with significant difference (PV= 0.017). Over use was in a great proportion of patients (36cases=35%) as unnecessary, improper combination and broad spectrum regimen.

Conclusion: Vancomycin was overused irrationally in a great proportion of patients. There was no serum level monitoring. Microbial resistance, serum trough level monitoring programs and continuous medical education for physicians can be effective in rational use of antibiotic.


Vancomycin, Evaluation, Rational Use, Pediatrics

Full Text:



Susan J. Rehm, MD Jennifer K. Sekeres, Elizabeth Neuner, Guidelines for Antimicrobial Usage. Pharm D Professional Communications Inc. Cleveland Clinic 2012-2013.

Mandell, Douglas & Bennett. Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Churchill Livingston; 2015: 377-400.

Shuli Svetitsky, Leonard Leibovici, and Mical Paul. Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis_ Antimicrobial Agents And Chemotherapy 2009; 53(10): 4069–4079.

Catherine Liu et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children. CID 2011:52 (1): e18-55.

Daniela Oliveira de Melo, Marli Sasaki, Renato Satovschi Grinbaum. Vancomycin Use in A Hospital with High Prevalence of Methicillin-Resistant Staphylococcus aureus: Comparison with Hospital Infection Control Practices Advisory Committe Guidelines (HICPAC) BJID 2007; 11:53-56.

Wasam Liaqat Tarar, Mehreen Farooq, Fatima Amin1, Khawaja Tahir Mahmood. Drug Utilization Evaluation of Vancomycin in Teaching Hospitals of Lahore. J. Pharm. Sci. & Res.2012;4(2):1728-1733.

Shoaei S, Bagherzadeh A, Haghighi M, Shabani M. Vancomycin and Five Broad-spectrum Antibiotic Utilization Evaluation in an Educational Medical Center in One Year. J Pharm Care 2014; 2 (4): 154-161.

Ayazkhoo L, Mousavi S, Ramazani F, Ayatollahi-Tafti M, Sa’dabadi Z, Sistanizad M. Vancomycin Utilization Evaluation: Are We Dosing Appropriately? J Pharm Care 2013; 1(4):149-152.

Salehifar E, Babamahmoodi F, Alikhani A, Ganji R, Fazli M. Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province. J Pharm Care 2014; 2(2): 55-59.

Hadi Hamishehkar, Davoud Ebrahimi, Ata Mahmoodpoor, Siminozar Mashayekhi, Parina Asgharian, Haleh Reazee. Drug Utilization Evaluation of Vancomycin in a Teaching Hospital In Tabriz-Iran. Pharmaceutical Sciences 2015; 21:25-29.

Melo D.O., Sasaki M., Grinbaum R.S. Vancomycin use in a Hospital with High Prevalence of Methicillin-Resistant Staphylococcus aureus:Comparison with Hospital Infection Control Practices Advisory Committee Guidelines (HICPAC). Braz J Infect Dis 2007; 11(1):53-7.

Saker Firas, Kesler Karen, Rosanbalm Shane, Morris Amy, Kapik Barry, Hetherington Seth. The use and misuse of vancomycin in very low birth weight infants. Journal of Neonatal-Perinatal Medicine 2008;1(4):217-220.

Daniela Oliveira de Melo, Eliane Ribeiro. Vancomycin use in a Brazilian teaching hospital: comparison with the Hospital Infection Control Practices Advisory Committee Guidelines (HICPAC). BJID 2009;13:161-4.

Alireza Davoudi, Narges Najafi, Aria Soleymani, lotfollah Davoodi, Hassan Asghari, Raziye Ehsani. Evaluation of antibiotic prescription pattern in Fatimah Zahra heart hospital of Sari, at north of Iran; one year survey. Int j med invest 2013; 2(3):143-150.

Mohammed Al Za’abi, Samreen Shafiq, Dawood Al Riyami, Badreldin H Ali. Utilization Pattern of Vancomycin in a University Teaching Hospital in Oman: Comparison with International Guidelines Trop J Pharm Res 2013;12(1): 117-121.

Fahimi F, Soleymani F, Tavakoli-Ardakani M. Vancomycin Utilization Evaluation in teaching hospital: A case- series study in Iran. J Pharm Care 2013; 1(2): 51-54.

Wendy A. Umberger, Judy Risko, Edward Covington. Appropriate Use of Vancomycin in a Pediatric Emergency Department Through the Use of a Standardized Electronic Guideline. Journal of Pediatric Nursing: 2015; 30(3):435-530.

Hing WC, Bek SJ, Lin RT, Li SC. A retrospective drug utilization evaluation of vancomycin usage in paediatric patients. J Clin Pharm Ther: 2004; 29(4):359-65.

Megan Bollinger et al. Vancomycin use in a rural hospital: a 3-year retrospective study. Can J Rural Med 2015; 20(2):56-62.

M.Askarian, O. Assadian, GhR. Safaee, A. Golkar, S. Namazi, M.R.Movahed. Vancomycin use in a Large teaching hospital in Shiraz, Islamic Republic of Iran, 2003. Eastern Mediterranean Health Journal. 2007; 13(5):1195-1201.